companydata.dkcompanydata.dk

OLANDER CLINICAL CONSULTING K/S: Financial statements 2025

CVR: 35860177

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

OLANDER CLINICAL CONSULTING K/S (CVR 35860177) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,099,449 and a net result of DKK 2,057,637 compared with DKK 2,004,688 the year before. That is an increase of 4.8% compared with the year before. Equity in the 2025 report amounted to DKK 303,261. The solvency ratio was 43.4%. The company had 1 employee in the financial year.

Gross Profit
DKK 2,099,449
Profit/Loss
DKK 2,057,637
Equity
DKK 303,261
Total Assets
DKK 698,523
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-2.1M2.1M303K1
2024-2M2M555K1
2023-1.9M1.9M622K0
2022-1.9M1.9M621K-
2021-1.8M1.8M687K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is OLANDER CLINICAL CONSULTING K/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

OLANDER CLINICAL CONSULTING K/S: The 2024 annual report is outJun 11, 2025

OLANDER CLINICAL CONSULTING K/S has published its annual report for 2024. Gross profit came to DKK 2,004,138, and the net result was DKK 2,004,688.

About OLANDER CLINICAL CONSULTING K/S

OLANDER CLINICAL CONSULTING K/S is a Danish company of the type Kommanditselskab based in Snekkersten, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 2,099,449 and a net result of DKK 2,057,637 compared with DKK 2,004,688 the year before. Equity in the 2025 report amounted to DKK 303,261.

Source: annual report 2025, Danish Business Authority